Silicosis is on the rise, but is there a therapeutic target?

Silicosis is on the rise, but is there a therapeutic target?
Signs of cell stress are (i) the presence of DNA (shown in blue) -- which is normally confined to the nucleus and mitochondria -- within the cytoplasm and outside of the cell and (ii) activation of the STING pathway accompanied by the formation of punctae (shown in red). Silica crystals engulfed by the cell are visible as translucent grains in the image on the right. Credit: David Gosset / P@CYFIC facility / CBM / CNRS

Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, which leads to silicosis, an incurable disease. Their study in mice and patients, published in Nature Communications (December 6th, 2018), shows that this inflammation can be prevented by extracellular DNA degradation, suggesting a new therapeutic target.

Provoked by inhalation, silicosis is a fatal disease, the only cure being transplantation. Though known as a miner's disease, it is far from a relic of the past: new operations using high-pressure sand—like denim sandblasting and fracking in shale gas extraction—expose workers and neighbor residents. Worldwide, silicosis still affects tens of millions of people, especially those active in the construction and mining industries, but also textile and dentistry professionals.

Once in the airways, silica microparticles provoke cell stress and death, and finally, and fibrosis (replacement of normal lung tissue with scar tissue). This leads to an irreversible reduction in respiratory capacity as silica is not eliminated. This is where Valérie Quesniaux's team at the Experimental and Molecular Immunology and Neurogenetics research laboratory (CNRS/University of Orléans) steps in. They looked at the mechanism underlying silica-induced lung inflammation.

In mice exposed to silica, the researchers showed that DNA released into the airways upon activates a signaling cascade known as the STING pathway. This pathway triggers lung inflammation that ultimately may develop into silicosis. They also demonstrated that treatment with DNase I, an enzyme that degrades the DNA released into the airways, prevents silica-induced lung .

The team worked with clinicians who for the last decade have been tracking a 21st-century silicosis epidemic in young men that has affected entire Turkish villages. The culprit is denim sandblasting to give jeans a fashionable used appearance. At Atatürk University, Metin Akgün and his colleagues noted a rise in the quantity of released DNA and inflammatory markers in the blood and sputum of patients. A high level of STING pathway activity was also detected in the lung tissue of patients with pulmonary fibrosis.

Thus the mechanism discovered in mice exposed to silica seems to also play a role in humans. The scientists' findings suggest that DNase I, already used in the treatment of other pathologies such as cystic fibrosis, might help patients exposed to silica.

More information: Sulayman Benmerzoug et al, STING-dependent sensing of self-DNA drives silica-induced lung inflammation, Nature Communications (2018). DOI: 10.1038/s41467-018-07425-1

Journal information: Nature Communications

Provided by CNRS
Citation: Silicosis is on the rise, but is there a therapeutic target? (2018, December 6) retrieved 5 December 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Researchers detail role of silica and lung cancer


Feedback to editors